Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Cryoport, Inc. Director's Dealing 2021

May 8, 2021

32876_dirs_2021-05-07_b1df9798-e21b-4ef4-a04b-a057e7129da0.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cryoport, Inc. (CYRX)
CIK: 0001124524
Period of Report: 2021-04-30

Reporting Person: HANCOCK DANIEL M (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-04-30 Option to purchase common stock $56.57 A 5416 Acquired 2028-04-30 Common Stock (5416) Direct
2021-04-30 Restricted Stock Rights $ A 2708 Acquired 2022-04-30 Common Stock (2708) Direct

Footnotes

F1: 1/12th of options vest on the 30th of the month for twelve months beginning May 30, 2021.

F2: Each restricted stock right represents a contingent right to receive one share of CYRX common stock.